ImmunityBio, Inc.: Form 10-Q for the period ended Mar 31, 2018
Filed with the SEC on May 7, 2018 and accepted by EDGAR at May 7, 2018, 16:06 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2018-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2018-01-01 to 2018-03-31 | $5.0k | us-gaap:Revenues |
| Research and development | 3 months2018-01-01 to 2018-03-31 | $14.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2018-01-01 to 2018-03-31 | $14.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2018-01-01 to 2018-03-31 | −$28.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2018-01-01 to 2018-03-31 | $33.0k | us-gaap:InterestExpense |
| Income tax | 3 months2018-01-01 to 2018-03-31 | −$124.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2018-01-01 to 2018-03-31 | −$27.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2018-01-01 to 2018-03-31 | −$0.35 | us-gaap:EarningsPerShareBasicAndDiluted |
| Capital expenditure | 3 months2018-01-01 to 2018-03-31 | $4.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 3 months2018-01-01 to 2018-03-31 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2018-03-31 | $11.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2018-03-31 | $126.8m | us-gaap:AssetsCurrent |
| Total assets | At period end2018-03-31 | $229.8m | us-gaap:Assets |
| Current liabilities | At period end2018-03-31 | $19.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2018-03-31 | $29.5m | us-gaap:Liabilities |
| Shareholders' equity | At period end2018-03-31 | $200.4m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001564590-18-011240. Last ingested by Listed: Nov 9, 2026, 17:45 ET. Listed shows no prices and gives no investment advice.